Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
about
Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalizedMolecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EMHuman Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional PoreCombinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization.Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeOral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in MiceNonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesImmune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo.Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesRecombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes.Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in miceImmunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cellsHuman rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivoNeutralization of HIV by milk expressed antibody.Why does the world need another rotavirus vaccine?A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animalsPlasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.Rotavirus vaccines: how they work or don't work.Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.Structural insights into the coupling of virion assembly and rotavirus replication.Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles.A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteinsInadequately treated wastewater as a source of human enteric viruses in the environment.The gastrointestinal frontier: IgA and virusesIntracellular antibody immunity.Purification of an IgA Monoclonal Antibody Specific for the Acr Protein of Mycobacterium tuberculosis by Immunoaffinity Chromatography.Mutations in toll-like receptor 3 are associated with elevated levels of rotavirus-specific IgG antibodies in IgA-deficient but not IgA-sufficient individuals.Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs.High-dimensional immune profiling of total and rotavirus VP6-specific intestinal and circulating B cells by mass cytometry.Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.Geometric mismatches within the concentric layers of rotavirus particles: a potential regulatory switch of viral particle transcription activity.Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.Impact of rotavirus vaccine introduction on rotavirus-associated seizures and a related possible mechanism.Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6.Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus.
P2860
Q27322604-1DF6F489-A3B9-4CFB-98D3-8B14879C648DQ27655706-E9E3C932-F928-4B14-96C4-A8D1BB50754AQ27678128-03715FAE-8376-4439-BC8B-3A487BC13D7FQ30550855-8881134C-636B-4D51-8EFB-26E858A36786Q33352435-9DA9B727-2826-4CBC-A232-64C935A2EBBAQ33551402-EBA28743-A50D-4246-9369-3320706D173CQ33740676-E230C26E-EAC7-4970-AF47-419FC2C3B23AQ34057711-30384860-7DCF-451B-BF7A-9442661427B8Q34291161-3FBB6871-7D53-4991-B984-56609777EAF5Q34407012-57AA9F97-8353-4B4B-B695-260AD75FB1F0Q34647668-5677C343-AF2B-417E-8F94-B1938DBF8769Q34711833-9491199F-EEB6-47D3-882C-415EDBAB93E8Q34742949-DA4C6C58-3FCC-4549-BA78-A5622BD4C3D6Q34907018-D50FFD9F-17FC-4D68-B29D-5EB9257B3148Q35636425-D4D433A2-6808-44E9-A5DB-CFD0C795CF54Q36276586-0B2EC182-6C72-4933-A843-FF4DA3FE7185Q36492710-967E72CC-704B-4CF5-BF9B-12F57DC48557Q36822928-C0452E94-5528-4967-AFC1-6A437619A904Q36844471-4A1ADBE4-AAEC-41E5-9E92-AD3345C2D4A2Q36891029-5DEBE6E2-AA0A-4384-A551-9701014DB062Q37081817-B5089BDC-5C69-44DE-957B-828EF553CF4FQ37135255-ED25D15F-AE62-4E84-9B79-485D27B71A0EQ37167334-4F1D28EE-B215-4B26-A7B5-C9DCD5262539Q37357576-007112ED-EF2F-433C-996A-5165A39BB958Q37370235-C74D4BD1-D2DE-4A0C-9DA8-8D155B5B72E0Q37444516-EE0CFDE6-0F3F-4C34-AE6D-86DA5750D439Q37715611-9C57B80D-9186-4FCA-B2D9-4026EA68368DQ37774248-CA8681AF-4989-4569-A152-1B018AB8D458Q38172132-03CF8AE0-A914-482F-AD4A-E88F80F87B01Q38203800-83BFBCE8-EA3F-427A-8C43-7885827CF66CQ38314240-C38F2AFB-6D30-4D69-9F52-A8539DC6536FQ38320849-FF160D58-0D5F-4CDD-A20A-08B164D8E424Q38828533-1DD023A1-613C-4758-BA63-C82D57383331Q38883836-8469663F-920F-4CD4-B3CE-464C7252A56FQ39290987-24520EF6-9D53-4184-AE58-C71C36E03A27Q39828279-45A12A96-945D-4E75-931E-B6CC1394C2DAQ39933471-158C506A-1AF8-4908-9696-8017DE5F4C7FQ40197032-61EC99E9-69B0-46C8-A85A-7665659F7850Q40617500-E7FDA600-D7A9-4852-B083-15EB28925784Q40641101-F4BF0CA4-A16E-4590-8517-7B9018270216
P2860
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@ast
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@en
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@nl
type
label
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@ast
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@en
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@nl
prefLabel
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@ast
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@en
Inhibition of rotavirus replic ...... otavirus VP6-specific IgA mAb.
@nl
P2093
P2860
P356
P1476
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb
@en
P2093
Jeffrey A Lawton
Joana Gilbert
Nelly Kuklin
Ningguo Feng
P2860
P304
P356
10.1172/JCI14397
P407
P577
2002-05-01T00:00:00Z